fluoxetine has been researched along with Morbid Obesity in 8 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have evaluated the weight loss of a selective inhibitor of serotonin uptake, fluoxetine, alone as compared with combined therapeutic trial with another serotoninergic drug, dexfenfluramine." | 5.08 | The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial. ( Halpern, A; Lima, N; Medeiros-Neto, G; Pedrinola, F; Sztejnsznajd, C, 1996) |
| " Alterations caused by RYGB could modify drug bioavailability and cause potential subtherapeutic plasma concentrations, increasing the risk of depressive relapse." | 1.91 | The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants. ( Eap, CB; Favre, L; Frantz, J; Garin, P; Vandenberghe, F; Vionnet, N, 2023) |
| "The treatment of fluoxetine significantly correlated with body mass index (T1: p < 0." | 1.30 | [The combined effect of psychotherapy and fluoxetine on obesity]. ( Haász, P; Jákó, P; Resch, M; Sidó, Z, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Garin, P | 1 |
| Favre, L | 1 |
| Vionnet, N | 1 |
| Frantz, J | 1 |
| Eap, CB | 1 |
| Vandenberghe, F | 1 |
| Guisado-Macías, JA | 1 |
| Méndez-Sánchez, F | 1 |
| Baltasar-Tello, I | 1 |
| Zamora-Rodríguez, FJ | 1 |
| Escudero-Sánchez, AB | 1 |
| Vaz-Leal, FJ | 1 |
| Soltanifar, S | 1 |
| Russell, R | 1 |
| Dolfing, JG | 1 |
| Wolffenbuttel, BH | 1 |
| ten Hoor-Aukema, NM | 1 |
| Schweitzer, DH | 1 |
| Aylwin, S | 1 |
| Al-Zaman, Y | 1 |
| Pedrinola, F | 1 |
| Sztejnsznajd, C | 1 |
| Lima, N | 1 |
| Halpern, A | 1 |
| Medeiros-Neto, G | 1 |
| Resch, M | 1 |
| Jákó, P | 1 |
| Sidó, Z | 1 |
| Haász, P | 1 |
| Dech, B | 1 |
| Budow, L | 1 |
1 review available for fluoxetine and Morbid Obesity
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria | 2008 |
1 trial available for fluoxetine and Morbid Obesity
| Article | Year |
|---|---|
The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial.
Topics: Adult; Aged; Body Mass Index; Drug Therapy, Combination; Female; Fenfluramine; Fluoxetine; Humans; L | 1996 |
6 other studies available for fluoxetine and Morbid Obesity
| Article | Year |
|---|---|
The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants.
Topics: Adult; Antidepressive Agents; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Gastric By | 2023 |
Fluoxetine, topiramate, and combination of both to stabilize eating behavior before bariatric surgery.
Topics: Adult; Anti-Obesity Agents; Bariatric Surgery; Drug Therapy, Combination; Feeding Behavior; Female; | 2016 |
Neuraxial anaesthesia for caesarean section in a patient with narcolepsy and cataplexy.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Antidepressive Agents, Second-Generation; Benz | 2010 |
Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.
Topics: Adult; Appetite Depressants; Bariatric Surgery; Female; Fluoxetine; Health Behavior; Humans; Life St | 2005 |
[The combined effect of psychotherapy and fluoxetine on obesity].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Fluoxetine; Huma | 1999 |
The use of fluoxetine in an adolescent with Prader-Willi syndrome.
Topics: Adolescent; Behavior Therapy; Feeding and Eating Disorders; Female; Fluoxetine; Hospitalization; Hum | 1991 |